Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosolic iron-sulfur assembly component 1 (CIAO1) is a WD40-repeat containing protein that is a core component of the cytosolic iron-sulfur protein assembly (CIA) complex. It mediates the incorporation of iron-sulfur clusters into a wide range of extramitochondrial Fe-S proteins involved in essential cellular activities such as metabolic pathways and DNA replication/repair. CIAO1 forms part of a multi-protein targeting complex with MMS19 and CIAO2A/CIAO2B, facilitating the last step of Fe-S cluster transfer to target proteins in the cytoplasm and nucleus. Dysfunction of CIAO1 is associated with severe mitochondrial and neurodegenerative syndromes due to the vital roles of its protein products and their cofactors in cell homeostasis. While CIAO1 is not yet a direct drug development target, WD-repeat proteins as a family are being investigated for their therapeutic potential in cancer, metabolism, neurology, and chromatin modification diseases.
No direct drugs; not considered a classic druggable target, mechanisms relate to modulation of protein-protein interactions in multi-protein iron-sulfur complex if targeted
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic iron-sulfur assembly component 1 (CIAO1).